Evaluation of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds
Public ClinicalTrials.gov record NCT03540004. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Single-blind, Multi-center Clinical Study Evaluating the Use of MolecuLight i:X as an Adjunctive Fluorescence Imaging Tool to Clinical Signs and Symptoms for the Identification of Bacteria-containing Wounds.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a non-randomized evaluation for which 160 adult patients will be imaged at outpatient wound care clinics who present with a wound of unknown infection diagnostic status and are receiving standard treatment. The MolecuLight i:X Imaging Device will be used as an adjunctive tool in the assessment of the wound and may be used to guide the targeted sampling of a wound (using a conventional punch biopsy method).
Study identification
- NCT ID
- NCT03540004
- Recruitment status
- Not listed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 367 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 23, 2018 (Actual)
- Primary completion
- Apr 9, 2019 (Actual)
- Completion
- Dec 30, 2020 (Estimated)
- Last update posted
- Mar 6, 2020
2018 – 2020
United States locations
- U.S. sites
- 14
- U.S. states
- 8
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| New Hope Podiatry Group | Los Angeles | California | 90063 | — |
| Royal Research Group | Pembroke Pines | Florida | 33027 | — |
| Saint Mary's Center for Wound Healing | Athens | Georgia | 30306 | — |
| The Wound Treatment Center at Opelousas General Health System | Opelousas | Louisiana | 70570 | — |
| Cleveland Foot and Ankle Clinic | Cleveland | Ohio | 44103 | — |
| The Heal Clinic | Tulsa | Oklahoma | 74136 | — |
| Foot and Ankle Center | Bryn Mawr | Pennsylvania | 19010 | — |
| Saint Vincent Health Center | Erie | Pennsylvania | 16544 | — |
| The Foot and Ankle Wellness Center of Western Pennsylvania | Ford City | Pennsylvania | 16226 | — |
| Armstrong County Memorial Hospital | Kittanning | Pennsylvania | 16201 | — |
| Serena Group Research Institute | Pittsburgh | Pennsylvania | 15222 | — |
| Martin Foot and Ankle | York | Pennsylvania | 17402 | — |
| El Campo Memorial Hospital | El Campo | Texas | 77437 | — |
| Texas Gulf Coast Medical Group | Houston | Texas | 77036 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03540004, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 6, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03540004 live on ClinicalTrials.gov.